Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Target Cell Response to Hormones

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

What is Cell Signaling?

What is Cell Signaling?

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.

What are Cells?

What are Cells?

Cells are the smallest and basic units of life, whether it is a single cell that forms the entire organism, e.g., in a bacterium or trillions of them, e.g., in humans. No matter what organism a cell is a part of, they share specific characteristics.
Basic Characteristics of Cells
A living cell has a plasma membrane, a bilayer of lipids that separates the aqueous solution inside the cell called the cytoplasm from the outside environment.
Furthermore, a living cell possesses genetic information...

Concentration Cells

Concentration Cells

A concentration cell is a type of a voltaic cell constructed by connecting two almost identical half-cells, both based on the same half-reaction and using the same electrode, differing only in the concentration of one redox species. A concentration cell's potential, therefore, is determined only by the concentration difference of the particular redox species.
Consider the following voltaic cell:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Distinct effects of CREBBP missense and truncating mutations.

Blood·2026

Same author

Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencing.

Leukemia·2025

Same author

Insights into the pathogenesis and biology of chronic lymphocytic leukemia through analysis of its B-cell receptor.

Leukemia & lymphoma·2025

Same author

Common origin and somatic mutation patterns of composite lymphomas and leukemias.

Leukemia·2025

Same author

Subgrouping germinal center-derived B-cell lymphomas based on machine learning-deduced DNA methylation modules.

Leukemia·2025

Same author

Single-cell analysis of a bi-clonal chronic lymphocytic leukemia reveals two clones with distinct gene expression pattern.

Leukemia & lymphoma·2024

Search research articles

Related Experiment Video

Updated: Jan 23, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

CD81 as target for B cell lymphomas.

Ralf Küppers¹

¹Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Medical Faculty, Essen, Germany ralf.kueppers@uk-essen.de.

The Journal of Experimental Medicine

|June 8, 2019

Summary

This summary is machine-generated.

A novel anti-CD81 antibody shows potential for treating B cell lymphomas. This immunotherapeutic approach demonstrated efficacy with minimal observed side effects on other CD81-positive immune cells.

More Related Videos

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

Related Experiment Videos

Last Updated: Jan 23, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

Area of Science:

Immunology
Oncology
Biotechnology

Background:

B cell lymphomas are malignancies of lymphocytes.
CD81 is a transmembrane protein expressed on various immune cells, including B cells.

Purpose of the Study:

To evaluate the therapeutic potential of a specific anti-CD81 antibody in treating B cell lymphomas.
To assess the safety profile of anti-CD81 antibody therapy concerning off-target effects on other immune cells.

Main Methods:

In vitro and in vivo studies using an anti-CD81 antibody.
Analysis of B cell lymphoma cell lines and primary samples.
Assessment of immune cell populations and their functions post-treatment.

Main Results:

The anti-CD81 antibody demonstrated significant efficacy against B cell lymphomas.
Despite widespread CD81 expression, the antibody exhibited a favorable safety profile with only minor side effects on analyzed CD81+ immune cells.

Conclusions:

The investigated anti-CD81 antibody represents a promising novel immunotherapeutic strategy for B cell lymphomas.
Targeting CD81 may offer a viable treatment option with manageable toxicity for these hematological malignancies.